Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 2/20 | 0.54 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 7/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6159315 | 0.96 | HRH1 (0.56) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL6160319 | 0.90 | CYP2A6 (0.64) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL6158950 | 0.90 | CYP2A6 (0.59) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL6161202 | 0.86 | HRH1 (0.59) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL6159264 | 0.86 | HRH1 (0.63) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL8091508 | 0.85 | CYP2A6 (0.49) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL8095259 | 0.80 | CYP2A6 (0.43) | CYP2A6HRH1TDP1L3MBTL1TBXAS1 | |
| SCHEMBL28012512 | 0.79 | L3MBTL1 (0.54) | CYP2A6HRH1CHRNA7TDP1L3MBTL1 | |
| SCHEMBL14244978 | 0.78 | HTR2A (0.53) | — | |
| SCHEMBL6159713 | 0.77 | CFTR (0.45) | CYP2A6TDP1L3MBTL1TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1129070-A4 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2005-03-02 | — | — | EP | disclosed |
| EP-1129070-A1 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-05 | — | — | EP | disclosed |
| US-6228872-B1 | PEPTIDE-PROLYL ISOMERASE AND ROTAMASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2001-05-08 | — | — | US | disclosed |
| WO-2000027811-A1 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |